1. Home
  2. PHAR vs PAHC Comparison

PHAR vs PAHC Comparison

Compare PHAR & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • PAHC
  • Stock Information
  • Founded
  • PHAR 1988
  • PAHC 1946
  • Country
  • PHAR Netherlands
  • PAHC United States
  • Employees
  • PHAR N/A
  • PAHC N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • PAHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHAR Health Care
  • PAHC Health Care
  • Exchange
  • PHAR Nasdaq
  • PAHC Nasdaq
  • Market Cap
  • PHAR 627.5M
  • PAHC 682.5M
  • IPO Year
  • PHAR N/A
  • PAHC 2014
  • Fundamental
  • Price
  • PHAR $8.58
  • PAHC $22.34
  • Analyst Decision
  • PHAR Strong Buy
  • PAHC Sell
  • Analyst Count
  • PHAR 3
  • PAHC 4
  • Target Price
  • PHAR $27.00
  • PAHC $20.50
  • AVG Volume (30 Days)
  • PHAR 7.3K
  • PAHC 145.8K
  • Earning Date
  • PHAR 10-24-2024
  • PAHC 02-05-2025
  • Dividend Yield
  • PHAR N/A
  • PAHC 2.15%
  • EPS Growth
  • PHAR N/A
  • PAHC N/A
  • EPS
  • PHAR N/A
  • PAHC 0.43
  • Revenue
  • PHAR $285,745,000.00
  • PAHC $1,046,762,000.00
  • Revenue This Year
  • PHAR $20.89
  • PAHC $27.25
  • Revenue Next Year
  • PHAR $11.15
  • PAHC $14.13
  • P/E Ratio
  • PHAR N/A
  • PAHC $51.99
  • Revenue Growth
  • PHAR 30.64
  • PAHC 7.17
  • 52 Week Low
  • PHAR $6.65
  • PAHC $10.04
  • 52 Week High
  • PHAR $13.20
  • PAHC $25.98
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 53.32
  • PAHC 39.62
  • Support Level
  • PHAR $8.71
  • PAHC $22.02
  • Resistance Level
  • PHAR $9.59
  • PAHC $24.42
  • Average True Range (ATR)
  • PHAR 0.33
  • PAHC 0.72
  • MACD
  • PHAR 0.11
  • PAHC -0.15
  • Stochastic Oscillator
  • PHAR 51.03
  • PAHC 12.92

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: